Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have launched an innovative biomedical study aboard the International Space Station to observe how three-dimensional human tumor models respond to chemotherapy in microgravity. Because cells grow and interact differently without Earth’s gravitational pull, orbital laboratories allow oncologists to uncover hidden mechanisms of drug resistance and tumor progression. The insights gained from this space-based research aim to accelerate more effective, personalized cancer treatments for patients on Earth.
About the Author
